Caris Life Sciences Inc expected to post earnings of 1 cent a share - Earnings Preview

Caris Life Sciences

04/08/2026 24:11

Caris Life Sciences Inc CAI.OQ CAI.O is expected to  show a rise in quarterly revenue when it reports  results on August 5 for the period ending June 30 2026
The Irving Texas-based  company is expected to report a 31.3% increase in revenue to $238.125 million from $181.4 million a year ago, according to the mean estimate from 12 analysts, based on LSEG data.
​LSEG's mean analyst estimate for Caris Life Sciences Inc is for earnings of 1 cent per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 9 "strong buy" or "buy," 3 "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for Caris Life Sciences Inc is $27.50, about 68.5% above its last closing price of $16.32
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.02
-0.02
0.00
Beat
100
Dec. 31 2026
0.10
0.03
0.28
Beat
787.2
Sep. 30 2025
-0.21
-0.21
0.08
Beat
139​
Jun. 30 2025
-0.20
-0.20
-7.97
Missed
-3,885
​​
​
This summary was machine generated August 3 at 23:11 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)